• Citer

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide.

par Rustin, Gordon J S;Timmers, P;Nelstrop, Ann;Shreeves, Gavin;Bentzen, Soeren M.;Baron, Benoît;Piccart-Gebhart, Martine ;Bertelsen, K;Stuart, G;Cassidy, J;Eisenhauer, Elizabeth
Référence Journal of clinical oncology, 24, 1, page (45-51)
Publication Publié, 2006-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide.
Auteur:	Rustin, Gordon J S; Timmers, P; Nelstrop, Ann; Shreeves, Gavin; Bentzen, Soeren M.; Baron, Benoît; Piccart-Gebhart, Martine; Bertelsen, K; Stuart, G; Cassidy, J; Eisenhauer, Elizabeth
Informations sur la publication:	Journal of clinical oncology, 24, 1, page (45-51)
Statut de publication:	Publié, 2006-01
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	CA-125 Antigen -- blood
	Cisplatin -- administration & dosage
	Cyclophosphamide -- administration & dosage
	Disease Progression
	Female
	Humans
	Ovarian Neoplasms -- blood
	Ovarian Neoplasms -- drug therapy
	Ovarian Neoplasms -- mortality
	Paclitaxel -- administration & dosage
	Retrospective Studies
Note générale:	Clinical Trial, Phase III
	Comparative Study
	Journal Article
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2005.01.2757
	info:pii/24/1/45
	info:pmid/16382112